To Evaluate the QoL Improvement of Oral Oligo Fucoidan in Subjects Receiving Platinum-based Chemotherapy With NSCLC

NCT03130829 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped target population is insufficient

Conditions

NSCLC Stage IV
NSCLC, Stage III

Interventions

DIETARY_SUPPLEMENT: Oligo Fucoidan
DIETARY_SUPPLEMENT: Placebo

Sponsor

Hi-Q Marine Biotech International, Ltd.